Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation.Atrial fibrillation, or AFib, is the most common type of irregular heartbeat.Kuck KH, Brugada J, Furnkranz A, et al, for the FIRE AND ICE Investigators.
The American Heart Association explains afib medications, managing your prescriptions for afib, such as Blood thinners anticoagulants and much more.In an effort to improve patient safety, Schillig et al implemented an inpatient Pharmacist-Directed Anticoagulation Service (PDAS) to help patients reduce the risks associated with initiation of Coumadin when transitioning from the inpatient to the outpatient setting.
Amiodarone has antiarrhythmic effects that overlap all 4 Vaughn-Williams antiarrhythmic classes.The Internet Journal. and for converting atrial fibrillation to.
These drugs slow AV nodal conduction primarily by increasing vagal tone.Heparin augments the activity of antithrombin III and prevents the conversion of fibrinogen to fibrin.
Fibrosis and electrophysiological characteristics of the atrial appendage in patients with atrial fibrillation and structural heart disease.CHADS2 Score for Stroke Risk Assessment in Atrial Fibrillation.Use flecainide in conjunction with AV nodal blocking agents when given to patients in atrial fibrillation, because conversion to AFL with 1:1 conduction (producing fast ventricular rates) can occur.The goal of antiarrhythmic drug therapy is to reduce the duration and frequency of atrial fibrillation episodes, thus improving patient quality of life and symptoms.
The following algorithm incorporates clinical trial data on the safety and efficacy of antiarrhythmic agents.Apixaban is indicated to reduce risk of stroke and systemic embolism associated with nonvalvular atrial fibrillation.This included appropriate enrollment in the anticoagulation clinic, documented inpatient-to-outpatient provider contact, documented inpatient provider-to-anticoagulation clinic communication, and patient follow-up with the anticoagulation clinic within 5 days of discharge.Singh BN, Singh SN, Reda, et al, for the Sotalol Amiodarone Atrial Fibrillation Efficacy Trial (SAFE-T) Investigators.